Vaccines Market Research Reports & Industry Analysis
Key issues in the global vaccine market today include product safety, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.
The topic of vaccine safety became prominent during the mid 1970’s with increases in lawsuits filed on behalf of those presumably injured by the diphtheria, pertussis, and tetanus (DPT) vaccine. To respond to public health concerns, Congress passed the National Childhood Vaccine Injury Act (NCVIA) in 1986, which in turn led to the creation of the National Vaccine Program Office (NVPO) within the Department of Health and Human Services (DHHS). NCVIA requires that all healthcare providers who administer vaccines containing diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b and varicella provide a Vaccine Information Statement (VIS) to the vaccine recipient, their parent or legal guardian prior to each dose. Each VIS contains a brief description of the disease as well as the risks and benefits of the vaccine. The NCVIA also mandated that all healthcare providers report certain adverse events that occur following vaccination. As a result, the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink Project (VSD) were established in 1990. VAERS provides a mechanism for the collection and analysis of adverse events associated with vaccines currently licensed in the U.S.; VSD involved forming partnerships with four large health maintenance organizations (HMOs) to continually monitor vaccine safety. The National Vaccine Injury Compensation Program, which was also created by NCVIA, compensates those individuals who have been injured by vaccines on a no-fault basis. On a global basis, the World Health Organization (WHO) is actively involved in ensuring the quality of vaccines.
Vaccines Industry Research & Market Reports
-
Cancer Vaccines: Analytical Tool
... turbocharged with the event of immune-checkpoint inhibitors. Cancer Vaccines: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on top of this hot and ... Read More
-
Global Peptide Cancer Vaccine Market Research Report 2018
... this report analyzes the top manufacturers in global and major regions, and splits the Peptide Cancer Vaccine market by product type and applications/end industries. The major players in global Peptide Cancer Vaccine market include TapImmune ... Read More
-
Global Vaccine Market: Focus on Product Type (Next-Generation Vaccine), Route of Administration, Disease Type, 22 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2018-2028
... They produce immunity by injecting components and agents inside the body. They greatly reduce the risk of infection by working with the natural defense of the body to safely develop immunity to a disease. Vaccines ... Read More
-
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2025, NAIC 325414
... will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $46,813 million by 2025. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry, including Average EBITDA, Operating ... Read More
-
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2018: Deal trends, players and financials
... detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors ... Read More
-
Global Vaccine Partnering Terms and Agreements 2010-2018: Deal trends, players and financials
... vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active ... Read More
-
Global Cancer Vaccine Partnering 2010-2018: Deal trends, players and financials
... worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value This report provides details ... Read More
-
Global Animal Vaccines Market 2018-2022
... processes, the same as human vaccines, before they gain a product license for sale. Technavio’s analysts forecast the Global Animal Vaccines Market to grow at a CAGR of 4.84% during the period 2018-2022. Covered in ... Read More
-
China Human Vaccine Industry Report, 2018-2022
... has remained at around 650 million doses over the past three years. China Food and Drug Administration (CFDA) approved the launch of 9-valent human papillomavirus vaccine (saccharomyces cerevisiae) and oral 5-valent reassortant rotavirus attenuated live ... Read More
-
United States Influenza Vaccines Market Report, Analysis and Forecast to 2025
... Forecast to 2025” presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual ... Read More
-
Global Human Vaccine Market 2018-2022
... mortality rates, and life expectancy. Technavio’s analysts forecast the Global Human Vaccine Market to grow at a CAGR of 7.73% during the period 2018-2022. Covered in this report The report covers the present scenario and ... Read More
-
Global Polio Vaccines Market 2018-2022
... OPV and IPV. The incidence of polio has been decreasing owing to initiatives by governments globally to drive immunization against the infection. Technavio’s analysts forecast the Global Polio Vaccines Market to grow at a CAGR ... Read More
-
Global Viral Vector Manufacturing Markets and Technologies Through 2022
... manufacturing market, and potential application sectors across various industries. The viral vector vaccine manufacturing market is broken down by types, application and diseases. Revenue forecasts from 2017 to 2022 are given for each product type, ... Read More
-
Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts
... the worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value This report provides ... Read More
-
Human Vaccines (Pediatric Vaccines, and Adult Vaccines)
... analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these ... Read More
-
Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecasts to 2023
... is projected to grow at a CAGR of 21.7% during the forecast period.” The global viral clearance market is expected to reach USD 724.5 million by 2023 from an estimated USD 271.2 million in 2018, ... Read More
-
Global Pediatric Vaccine Market - Technologies, Market share and Industry Forecast to 2024
... contributing the growth of global pediatric vaccine market includes, rise in importance and awareness of immunization across the globe predominance of chronic diseases, technologic advancements and increase in government and non-government funding. However, cost of ... Read More
-
Global Vaccine Refrigerators Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
... need to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradation of vaccines and other products, along with options like alarms and backup ... Read More
-
HIDA 2018 Influenza Vaccine Production & Distribution Market Brief
... chain and key information from the eighth annual “HIDA Flu Products Survey” of distributors conducted in May 2018. The survey demonstrates the essential role that distributors will serve during the 2018-2019 flu season by helping ... Read More
-
Veterinary Vaccines (Canine Vaccines, Feline Vaccines, Livestock Vaccines, etc.)
... Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are ... Read More
-
Global Vaccines
... segmented in terms of: pneumococcal; combination; measles, mumps, and rubella; varicella; and other pediatric vaccines such as polio, hepatitis, and haemophilus influenzae type b. Global demand for adult vaccines is segmented in terms of: influenza; ... Read More
-
Hydrophobic Interaction Chromatography Market by Product & Services (Resin, Columns (Empty, Prepacked), Buffer), Sample (Monoclonal Antibodies, Vaccines), End User (Pharmaceutical Companies, CROs & CMOs, Research Institutes) - Global Forecast to 2023
... interaction chromatography market is projected to grow at a CAGR of 7.5%.” The global hydrophobic interaction chromatography market is projected to reach USD 418.2 million in 2023 from USD 291.3 million in 2018, at a ... Read More
-
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Peptide Cancer Vaccine Market 2018, Forecast to 2023
... clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. Scope of the Report: This ... Read More
-
Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023
... projected to grow at a CAGR of 6.7%” The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Rising prevalence of diseases, ... Read More
-
Veterinary Vaccines - Global Market Outlook (2017-2026)
... a CAGR of 6.9% from 2017 to 2026. Growing figure of livestock disease, Increasing Adoption of Companion Animals and Rising frequency of Zoonotic diseases are some of the factors that are fuelling the market growth. ... Read More
